Moderna Inc.

NAS: MRNA

GO
/marketstate/country/us

Before the Bell

 --Real time quotes

Jan 31, 2023, 9:05 a.m.

/zigman2/quotes/205619834/composite

$

176.00

Change

-4.87 -2.69%

Volume

Volume 53,804

Real time quotes

/zigman2/quotes/205619834/composite

Previous close

$ 180.87

$ 180.87

Change

-8.48 -4.48%

Day low

Day high

$180.64

$187.59

Open

52 week low

52 week high

$115.03

$217.25

Open

Company Description

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therap...

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid (mRNA). Its product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rose and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Valuation

P/E Current

6.69

P/E Ratio (with extraordinary items)

6.63

P/E Ratio (without extraordinary items)

8.97

Price to Sales Ratio

5.95

Price to Book Ratio

7.24

Price to Cash Flow Ratio

8.05

Enterprise Value to EBITDA

4.67

Enterprise Value to Sales

2.96

Efficiency

Total Asset Turnover

1.14

Liquidity

Current Ratio

1.76

Quick Ratio

1.60

Cash Ratio

1.18

Profitability

Gross Margin

84.53

Operating Margin

71.89

Pretax Margin

72.15

Net Margin

66.27

Return on Assets

75.78

Return on Equity

146.08

Return on Total Capital

148.24

Capital Structure

Total Debt to Total Assets

3.68

Officers and Executives

Name Age Officer Since Title
Mr. Stéphane Bancel 48 - President, Founding CEO & Director
Dr. Stephen Hoge 45 - SVP-Corporate Development & New Drug Concepts
Mr. James M. Mock 44 2022 Chief Financial Officer
Dr. Paul Burton 52 2021 Chief Medical Officer
Mr. Juan Andres 56 2017 Chief Technical Operations & Quality Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
01/05/2023 Stéphane Bancel
Chief Executive Officer; Director
975   Disposition at $175.1 per share. 170,722
01/05/2023 Stéphane Bancel
Chief Executive Officer; Director
13,460   Disposition at $174.38 per share. 2,347,154
01/05/2023 Stéphane Bancel
Chief Executive Officer; Director
14,816   Disposition at $173.42 per share. 2,569,390
01/05/2023 Stéphane Bancel
Chief Executive Officer; Director
10,749   Disposition at $172.64 per share. 1,855,707
01/05/2023 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
01/04/2023 Noubar B. Afeyan
Director
10,000   Disposition at $182.15 per share. 1,821,500
12/29/2022 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $178.19 per share. 1,781,900
12/29/2022 Stéphane Bancel
Chief Executive Officer; Director
800   Disposition at $182.13 per share. 145,704
12/29/2022 Stéphane Bancel
Chief Executive Officer; Director
2,602   Disposition at $181.07 per share. 471,144
12/29/2022 Stéphane Bancel
Chief Executive Officer; Director
15,890   Disposition at $180.25 per share. 2,864,172
12/29/2022 Stéphane Bancel
Chief Executive Officer; Director
20,708   Disposition at $179.31 per share. 3,713,151
12/29/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $209.82 per share. 2,098,200
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
759   Disposition at $208.13 per share. 157,970
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
2,872   Disposition at $207.33 per share. 595,451
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
9,093   Disposition at $206.39 per share. 1,876,704
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
11,981   Disposition at $205.5 per share. 2,462,095
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
8,379   Disposition at $204.47 per share. 1,713,254
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
6,216   Disposition at $203.56 per share. 1,265,328
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
700   Disposition at $202.35 per share. 141,645
12/22/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
271   Disposition at $210.16 per share. 56,953
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
4,307   Disposition at $209.3 per share. 901,455
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
11,131   Disposition at $208.66 per share. 2,322,594
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
8,833   Disposition at $207.46 per share. 1,832,494
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
5,775   Disposition at $206.64 per share. 1,193,346
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
3,183   Disposition at $205.51 per share. 654,138
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
6,500   Disposition at $203.46 per share. 1,322,490
12/21/2022 Noubar B. Afeyan
Director
10,000   Disposition at $201.7 per share. 2,017,000
12/21/2022 Juan Andres
See remarks
2,000   Disposition at $201.7 per share. 403,400
12/21/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/21/2022 Juan Andres
See remarks
2,000   Derivative/Non-derivative trans. at $20.93 per share. 41,860
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $207.88 per share. 2,078,800
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
200   Disposition at $208.03 per share. 41,606
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
20,200   Disposition at $207.37 per share. 4,188,874
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
1,700   Disposition at $205.93 per share. 350,081
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
10,091   Disposition at $204.67 per share. 2,065,324
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
7,809   Disposition at $203.9 per share. 1,592,255
12/15/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
300   Disposition at $216.76 per share. 65,028
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
1,116   Disposition at $216.1 per share. 241,167
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
2,928   Disposition at $215.07 per share. 629,724
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
7,321   Disposition at $214.09 per share. 1,567,352
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
5,580   Disposition at $213.06 per share. 1,188,874
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
6,598   Disposition at $212.13 per share. 1,399,633
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
7,120   Disposition at $211.17 per share. 1,503,530
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
3,156   Disposition at $210.12 per share. 663,138
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
1,293   Disposition at $209.03 per share. 270,275
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
888   Disposition at $207.99 per share. 184,695
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
600   Disposition at $206.49 per share. 123,894
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
800   Disposition at $204.47 per share. 163,576
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
400   Disposition at $203.17 per share. 81,268
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
1,200   Disposition at $200.65 per share. 240,780
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
700   Disposition at $199.88 per share. 139,916
12/14/2022 Juan Andres
See remarks
2,000   Disposition at $195 per share. 390,000
12/14/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/14/2022 Juan Andres
See remarks
2,000   Derivative/Non-derivative trans. at $20.93 per share. 41,860
12/08/2022 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $179.12 per share. 1,791,200
12/08/2022 Stéphane Bancel
Chief Executive Officer; Director
1,038   Disposition at $184.88 per share. 191,905
12/08/2022 Stéphane Bancel
Chief Executive Officer; Director
7,622   Disposition at $184.25 per share. 1,404,353
12/08/2022 Stéphane Bancel
Chief Executive Officer; Director
19,078   Disposition at $183.05 per share. 3,492,227
12/08/2022 Stéphane Bancel
Chief Executive Officer; Director
12,262   Disposition at $182.19 per share. 2,234,013
12/08/2022 Shannon Thyme Klinger
Chief Legal Officer
490   Disposition at $179.15 per share. 87,783
12/08/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
600   Disposition at $180.11 per share. 108,066
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
10,557   Disposition at $179.49 per share. 1,894,875
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
4,961   Disposition at $178.23 per share. 884,199
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
15,826   Disposition at $177.3 per share. 2,805,949
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
7,613   Disposition at $176.56 per share. 1,344,151
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
443   Disposition at $175.26 per share. 77,640
12/07/2022 Juan Andres
See remarks
2,000   Disposition at $172.16 per share. 344,320
12/07/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
12/07/2022 Juan Andres
See remarks
2,000   Derivative/Non-derivative trans. at $20.93 per share. 41,860
12/07/2022 Shannon Thyme Klinger
Chief Legal Officer
1,139   Derivative/Non-derivative trans. at $0 per share. 0
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
10,000   Disposition at $173.41 per share. 1,734,100
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
1,804   Disposition at $183.46 per share. 330,961
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
7,832   Disposition at $182.65 per share. 1,430,514
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
6,321   Disposition at $181.58 per share. 1,147,767
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
12,331   Disposition at $180.53 per share. 2,226,115
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
11,712   Disposition at $179.62 per share. 2,103,709
12/01/2022 Stéphane Bancel
Chief Executive Officer; Director
40,000   Derivative/Non-derivative trans. at $0.99 per share. 39,600
/news/latest/company/us/mrna

MarketWatch News on MRNA

  1. Moderna Inc. stock underperforms Monday when compared to competitors

    4:31 p.m. Jan. 30, 2023

    - MarketWatch Automation

  2. Moderna’s RSV vaccine gets Breakthrough Therapy status

    7:26 a.m. Jan. 30, 2023

    - Jaimy Lee

  3. Moderna Inc. stock falls Friday, underperforms market

    4:31 p.m. Jan. 27, 2023

    - MarketWatch Automation

  4. Moderna Inc. stock rises Thursday, still underperforms market

    4:31 p.m. Jan. 26, 2023

    - MarketWatch Automation

  5. Moderna Inc. stock falls Wednesday, underperforms market

    4:31 p.m. Jan. 25, 2023

    - MarketWatch Automation

  6. Moderna Inc. stock falls Tuesday, still outperforms market

    4:31 p.m. Jan. 24, 2023

    - MarketWatch Automation

  7. Moderna Inc. stock rises Monday, still underperforms market

    4:31 p.m. Jan. 23, 2023

    - MarketWatch Automation

  8. Moderna Inc. stock rises Friday, still underperforms market

    4:31 p.m. Jan. 20, 2023

    - MarketWatch Automation

  9. Moderna Inc. stock underperforms Thursday when compared to competitors

    4:31 p.m. Jan. 19, 2023

    - MarketWatch Automation

  10. Moderna Inc. stock outperforms competitors on strong trading day

    4:31 p.m. Jan. 18, 2023

    - MarketWatch Automation

  11. Chegg, Bluebird Bio, Yeti, J.B. Hunt, and More Market Movers

    4:14 p.m. Jan. 18, 2023

    - Emily Dattilo

  12. Moderna Sees Success in RSV Vaccine Trial

    10:05 a.m. Jan. 18, 2023

    - Josh Nathan-Kazis

  13. Loading more headlines...
/news/nonmarketwatch/company/us/mrna

Other News on MRNA

  1. How Biden Officials Bungled a Better Vaccine

    5:20 p.m. Jan. 29, 2023

    - Allysia Finley

  2. Top 5 4th Quarter Trades of ARS Investment Partners, LLC

    6:00 p.m. Jan. 25, 2023

    - GuruFocus.com

  3. Baillie Gifford Slashes Meta, Boosts Nvidia

    5:11 p.m. Jan. 25, 2023

    - GuruFocus.com

  4. Johnson & Johnson Profit Falls 25%

    4:45 p.m. Jan. 24, 2023

    - Peter Loftus

  5. The Deceptive Campaign for Bivalent Covid Boosters

    3:10 p.m. Jan. 22, 2023

    - Allysia Finley

  6. Stocks Fall After Retail and Inflation Data

    4:27 p.m. Jan. 18, 2023

    - Joe Wallace

  7. Moderna Finds Life After Covid-19

    12:21 p.m. Jan. 18, 2023

    - David Wainer

  8. J&J Slashes Production of Its Covid-19 Vaccine

    10:45 a.m. Jan. 13, 2023

    - Jared S. Hopkins

  9. Aurora Investment Managers, LLC. Buys 3, Sells 2 in 4th Quarter

    4:00 p.m. Jan. 11, 2023

    - GuruFocus.com

  10. Old Port Advisors Buys 3, Sells 2 in 4th Quarter

    2:00 p.m. Jan. 11, 2023

    - GuruFocus.com

  11. Moderna Considers Price of $110-$130 for Covid-19 Vaccine

    1:40 p.m. Jan. 9, 2023

    - Peter Loftus

  12. China to Allow Rapid Tests to Confirm Covid Cases

    7:50 a.m. Jan. 6, 2023

    - Rachel Liang

  13. China’s mRNA Covid Vaccine Starts Test Production

    5:36 a.m. Jan. 6, 2023

    - Joyu Wang

  14. Corporate Insiders Aren’t Betting on a Market Rebound

    7:00 a.m. Jan. 5, 2023

    - Jack Pitcher

  15. Western Covid Medicine to China’s Rescue

    6:59 p.m. Dec. 28, 2022

    - The Editorial Board

  16. Boring Was King of Healthcare in 2022

    10:28 a.m. Dec. 28, 2022

    - David Wainer

  17. Loading more headlines...

At a Glance

Moderna, Inc.

200 Technology Square

Cambridge, Massachusetts 02139

Phone

1 6177146500

Industry

-

Sector

-

Fiscal Year-end

12/2022

Revenue

$18.41B

Net Income

$12.20B

Employees

2,700

/news/pressrelease/company/us/mrna

Press Releases on MRNA

  1. Learn to Evaluate Moderna Inc. Common Stock (MRNA) using the Charts

    9:14 p.m. Jan. 20, 2023

    - Stock Traders Daily

  2. Nasdaq 100 Movers: KHC, MRNA

    1:17 p.m. Jan. 18, 2023

    - MarketNewsVideo.com

  3. S&P 500 Movers: PNC, MRNA

    1:15 p.m. Jan. 18, 2023

    - MarketNewsVideo.com

  4. Moderna Inc. Common Stock MRNA Trading Report

    7:05 a.m. Jan. 11, 2023

    - Stock Traders Daily

  5. Moderna Stock Rises on Positive Business Outlook

    1:25 p.m. Jan. 10, 2023

    - PressReach.com

  6. Moderna to Acquire OriCiro Genomics

    7:00 a.m. Jan. 4, 2023

    - ACCESSWIRE

  7. Moderna Inc. Common Stock MRNA Trading Report

    3:55 p.m. Jan. 1, 2023

    - Stock Traders Daily

  8. S&P 500 Movers: MRNA, KR

    10:16 a.m. Dec. 30, 2022

    - MarketNewsVideo.com

  9. Nasdaq 100 Movers: MRNA, PAYX

    10:27 a.m. Dec. 23, 2022

    - MarketNewsVideo.com

  10. S&P 500 Movers: MRNA, COP

    10:22 a.m. Dec. 23, 2022

    - MarketNewsVideo.com

  11. Loading more headlines...
Link to MarketWatch's Slice.